Fluence Energy, Inc., through its subsidiaries, provides energy storage and optimization software for renewables and storage applications in the Americas, the Asia Pacific, Europe, the Middle East, and Africa.
Positioning no disclosures inside 60 days, left as found
Options put/call open interest 0.84, read 2026-11-05
Ethical passes the values gate
Price5.27 USD
Fair value7.00
Ethical score70.0/100
Value readUndervaluedas of 6 Nov 2026
Our investment reviews on this name
2026-08-29Read Markdown11.08-52.4% to today ✓Distribution gives way to Markdown after a 21% slide in 4 weeks
2026-07-30Read Distribution14.07-62.5% to today ✓Markup gives way to Distribution after a 41% slide in 4 weeks
2026-07-02Read Markup23.71-77.8% to today First review on file: Markup
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Fluence Energy, Inc. holds its Distribution at $5.27. The statistical read favours the sellers, held for 71 days.
As held on the ledger · 2026-11-06
Phase
Distribution · caution
Quantitative state
The statistical read favours the sellers, held for 71 days
Price at the screen
$5.27
Valuation
N/A trailing · -11.42 forward price to earnings
Values screen
PASS· score 70.0
Beta
2.79
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
16.58%
Below 33%
Interest-bearing debt is just 16.6% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
42.01%
Below 49%
Money owed to the company is 42.0% of assets, under the 49% limit.
Pass
Revenue purity
0.21%
Below 5%
Only 0.2% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Clears, in Plain English
Fluence Energy, clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 17%, inside the ~33% line, and almost none of its income is interest, so it passes.
Read as at 2026-11-07. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when FLNC's ethical verdict changes
Today FLNC passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 6 Nov 2026: it trades at roughly a 25% discount to our $7.00 fair value, 7.90% revenue growth.
Fair value range in USD, drawn from the 2026-11-06 screen. The gold marker is the market price at the same screen. A 24.7% discount to the base estimate.
Where our models see it going: fair-value estimate $7.00, with a range of $3.00 to $10.54, dated to the 2026-11-06 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Storage hype runs into red ink
Picture the scramble to back up wind and solar with big batteries, and Fluence looks like the outfit that should be riding that wave. Yet the numbers tell a different story. Shares sit at 14 dollars while fair value sits at 10, a 72 times forward earnings multiple for a business still posting an 8 percent revenue rise, minus 2 percent margins and minus 13 percent return on equity. The ethical screen is clear, but the valuation and profitability screens are not.
We pass because nothing here shows durable advantage or cash generation that justifies the price. Eighteen analysts sit on a hold rating with an 18 dollar median target, yet the gap between that optimism and the actual books remains wide. Unknown moat and single-digit growth leave little room for error in a sector full of bigger players.
Execution risk in new markets and pressure from cheaper competitors could keep margins under pressure for years. Peak earnings are not the issue here, but the absence of earnings is. Analysis, not advice.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
FLNC trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-04Markdown$5.50-7.3%Entry 10
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 7.3% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are up 339%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (17 analysts) rates it hold, with a mean price target of $18.
2026-10-28Markdown$5.93+0.0%Entry 9
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are up 339%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (17 analysts) rates it hold, with a mean price target of $18.
2026-10-21Markdown$5.93-20.2%Entry 8
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 20.2% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are up 339%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (17 analysts) rates it hold, with a mean price target of $18.
2026-10-14Markdown$7.43+0.5%Entry 7
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 0.5% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading neutral. Over the past year the shares are up 339%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (17 analysts) rates it hold, with a mean price target of $18.
2026-10-02Markdown$7.39-33.3%Entry 6
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 33.3% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading neutral. Over the past year the shares are up 339%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (17 analysts) rates it hold, with a mean price target of $18. Since the last review it entered the Titan Ethical 500; its composite score rose.
2026-08-29Markdown · changed$11.08-21.3%Entry 5
The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 21.3% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading neutral. Over the past year the shares are up 339%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (17 analysts) rates it hold, with a mean price target of $18.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 40.7% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading neutral. Over the past year the shares are up 339%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (17 analysts) rates it hold, with a mean price target of $18.
2026-07-18Markup$23.71+0.0%Entry 3
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading neutral. Over the past year the shares are up 339%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (17 analysts) rates it hold, with a mean price target of $18.
2026-07-03Markup$23.71+0.0%Entry 2
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.
2026-07-02Markup$23.71Entry 1
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.